Navigating the Challenges of Clinical Trials and Research Funding

This chapter examines the difficulties associated with unblinded clinical trials, particularly those funded by companies with vested interests. It highlights issues of data reliability, patient selection bias, and the broader implications of decreasing NIH funding on medical research.